Search

everythinglearnresearchcommunity

for

Search:↓

ZPK helps skin cells mature and may affect skin health.

RAPK is a rare skin disorder with pigmented spots, mainly on hands and feet, starting in youth.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

A feedback loop between LRH and RSL4 controls root hair growth in Arabidopsis.

BIK1 gene helps plants resist some pathogens but makes them more vulnerable to others.

JAK inhibitors show promise for treating various skin diseases.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Involucrin gene expression is controlled by specific proteins and signaling pathways.

AGC2-1 protein is essential for root hair growth in Arabidopsis.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Deleting Crif1 in mouse skin disrupts skin balance and hair growth.

Faulty LEF1 activation causes faster skin cell differentiation in premature aging syndrome.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

ICP5249 helps hair grow by activating a specific cell pathway.

17β-estradiol can reduce inflammation in the skin.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Ceramide synthase 4 is essential for maintaining skin barrier health.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.